Zhu David T, Park Andrew
Medical Scientist Training Program, School of Medicine, Virginia Commonwealth University, Richmond, VA, United States; School of Medicine, Virginia Commonwealth University, Richmond, VA, United States.
School of Medicine, Virginia Commonwealth University, Richmond, VA, United States.
Ann Epidemiol. 2025 Jan;101:36-41. doi: 10.1016/j.annepidem.2024.12.005. Epub 2024 Dec 18.
To analyze drug overdose mortality trends among Asian American and Native Hawaiian/Pacific Islander (AANHPI) populations.
We obtained data on drug overdose deaths and population totals from CDC WONDER and the American Community Survey (2018-2022). Crude mortality rates per 100,000 were calculated overall and by sex, U.S. Census Division, and drug type. Disaggregated analyses included six Asian American subgroups (Asian Indian, Chinese, Filipino, Japanese, Korean, and Vietnamese) and three NHPI subgroups (Native Hawaiian, Guamanian, and Samoan).
In 2022, Asian Americans had 1226 drug overdose deaths and NHPI individuals had 154. The mortality rate for NHPI individuals (17.52 [95 % CI: 14.76-20.29] per 100,000) tripled that of Asian Americans (5.85 [95 % CI: 5.52-6.18] per 100,000). Fentanyl was the leading drug-related death among Asian Americans (3.17 [95 % CI: 2.93-3.41] per 100,000), while methamphetamine led for NHPI individuals (11.38 [95 % CI: 9.15-13.61] per 100,000). Disaggregated mortality rates were highest for Korean Americans (9.06 [95 % CI: 8.88-9.24] per 100,000) and Guamanians (43.16 [95 % CI: 39.05-48.24] per 100,000) among the Asian American and NHPI subgroups, respectively.
AANHPI populations experience distinct overdose mortality patterns, with NHPI individuals and specific ethnic subgroups disproportionately affected, warranting targeted public health interventions.
分析亚裔美国人和夏威夷原住民/太平洋岛民（AANHPI）群体中药物过量致死率的趋势。
我们从美国疾病控制与预防中心（CDC）的WONDER数据库和美国社区调查（2018 - 2022年）中获取了药物过量死亡数据和人口总数。计算了总体以及按性别、美国人口普查分区和药物类型划分的每10万人的粗死亡率。分类分析包括六个亚裔美国人群体亚组（印度裔、华裔、菲律宾裔、日裔、韩裔和越南裔）和三个夏威夷原住民/太平洋岛民群体亚组（夏威夷原住民、关岛查莫罗人、萨摩亚人）。
2022年，亚裔美国人中有1226例药物过量死亡，夏威夷原住民/太平洋岛民群体中有154例。夏威夷原住民/太平洋岛民群体的死亡率（每10万人中有17.52例[95%置信区间：14.76 - 20.29]）是亚裔美国人死亡率（每10万人中有5.85例[95%置信区间：5.52 - 6.18]）的三倍。芬太尼是亚裔美国人中与药物相关死亡的主要原因（每10万人中有3.17例[95%置信区间：2.93 - 3.41]），而甲基苯丙胺是夏威夷原住民/太平洋岛民群体中导致死亡的主要药物（每10万人中有11.38例[95%置信区间：9.15 - 13.61]）。在亚裔美国人群体和夏威夷原住民/太平洋岛民群体亚组中，韩裔美国人（每10万人中有9.06例[95%置信区间：8.88 - 9.24]）和关岛查莫罗人（每10万人中有43.16例[95%置信区间：39.05 - 48.24]）的分类死亡率最高。
亚裔美国人和夏威夷原住民/太平洋岛民群体呈现出不同的药物过量致死模式，夏威夷原住民/太平洋岛民群体及特定族裔亚组受到的影响尤为严重，需要有针对性的公共卫生干预措施。
